Lori A. Worley

7.1k total citations · 4 hit papers
23 papers, 4.2k citations indexed

About

Lori A. Worley is a scholar working on Ophthalmology, Molecular Biology and Immunology. According to data from OpenAlex, Lori A. Worley has authored 23 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Ophthalmology, 14 papers in Molecular Biology and 10 papers in Immunology. Recurrent topics in Lori A. Worley's work include Ocular Oncology and Treatments (19 papers), Immunotherapy and Immune Responses (8 papers) and Retinal Development and Disorders (5 papers). Lori A. Worley is often cited by papers focused on Ocular Oncology and Treatments (19 papers), Immunotherapy and Immune Responses (8 papers) and Retinal Development and Disorders (5 papers). Lori A. Worley collaborates with scholars based in United States, Russia and Japan. Lori A. Worley's co-authors include J. William Harbour, Michael D. Onken, A. Bowcock, Justis P. Ehlers, Elisha Roberson, Shenghui Duan, Katie A. Matatall, Li Cao, Cynthia Helms and Hima Anbunathan and has published in prestigious journals such as Science, Journal of Biological Chemistry and Nature Genetics.

In The Last Decade

Lori A. Worley

23 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas

2010 1.0k citations J. William Harbour, Michael D. Onken et al. Science profile →
Gene Expression Profiling in Uveal Melanoma Reveals Two Molecular Classes and Predicts Metastatic Death

2004 514 citations Michael D. Onken, Lori A. Worley et al. Cancer Research profile →
Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis

2013 479 citations Dominic E. Sanford, Brian A. Belt et al. Clinical Cancer Research profile →
Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma

2013 374 citations J. William Harbour, Elisha Roberson et al. Nature Genetics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lori A. Worley United States	21	2.5k	2.1k	1.8k	1.3k	570	23	4.2k
Dietmar Lohmann Germany	33	2.1k 0.8×	1.9k 0.9×	1.6k 0.9×	394 0.3×	442 0.8×	98	3.8k
Emine Kılıç Netherlands	22	1.4k 0.6×	710 0.3×	634 0.4×	478 0.4×	232 0.4×	81	1.7k
Swapna S. Vemula United States	12	818 0.3×	1.1k 0.5×	1.1k 0.6×	354 0.3×	359 0.6×	19	2.0k
Helen Kalirai United Kingdom	25	1.2k 0.5×	847 0.4×	613 0.3×	509 0.4×	221 0.4×	89	1.8k
Nicole C. Naus Netherlands	23	1.1k 0.4×	562 0.3×	543 0.3×	355 0.3×	173 0.3×	59	1.5k
David Gentien France	29	334 0.1×	1.4k 0.7×	902 0.5×	268 0.2×	868 1.5×	83	2.7k
Malin Pedersen United Kingdom	22	164 0.1×	1.3k 0.6×	1.1k 0.6×	673 0.5×	293 0.5×	37	2.4k
Mert Sozen Türkiye	9	693 0.3×	687 0.3×	512 0.3×	270 0.2×	170 0.3×	20	1.3k
Lynn M.G. Gardner United States	7	197 0.1×	2.0k 1.0×	906 0.5×	269 0.2×	1.1k 1.9×	8	2.6k
Iris Moll Germany	19	129 0.1×	1.3k 0.6×	881 0.5×	543 0.4×	450 0.8×	28	2.5k

Countries citing papers authored by Lori A. Worley

Since Specialization

Citations

This map shows the geographic impact of Lori A. Worley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lori A. Worley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lori A. Worley more than expected).

Fields of papers citing papers by Lori A. Worley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lori A. Worley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lori A. Worley. The network helps show where Lori A. Worley may publish in the future.

Co-authorship network of co-authors of Lori A. Worley

This figure shows the co-authorship network connecting the top 25 collaborators of Lori A. Worley. A scholar is included among the top collaborators of Lori A. Worley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lori A. Worley. Lori A. Worley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pak, Linda M., Simon Haroutounian, William G. Hawkins, et al.. (2018). Epidurals in Pancreatic Resection Outcomes (E-PRO) study: protocol for a randomised controlled trial. BMJ Open. 8(1). e018787–e018787. 3 indexed citations

Panni, Roheena Z., Dominic E. Sanford, Brian A. Belt, et al.. (2014). Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancer. Cancer Immunology Immunotherapy. 63(5). 513–528. 173 indexed citations

Sanford, Dominic E., Brian A. Belt, Roheena Z. Panni, et al.. (2013). Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis. Clinical Cancer Research. 19(13). 3404–3415. 479 indexed citations breakdown →

Harbour, J. William, Elisha Roberson, Hima Anbunathan, et al.. (2013). Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma. Nature Genetics. 45(2). 133–135. 374 indexed citations breakdown →

Matatall, Katie A., Olga A. Agapova, Michael D. Onken, et al.. (2013). BAP1 deficiency causes loss of melanocytic cell identity in uveal melanoma. BMC Cancer. 13(1). 371–371. 112 indexed citations

Onken, Michael D., Lori A. Worley, & J. William Harbour. (2010). Association between Gene Expression Profile, Proliferation and Metastasis in Uveal Melanoma. Current Eye Research. 35(9). 857–863. 26 indexed citations

Harbour, J. William, Michael D. Onken, Elisha Roberson, et al.. (2010). Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas. Science. 330(6009). 1410–1413. 1024 indexed citations breakdown →

Onken, Michael D., et al.. (2010). An Accurate, Clinically Feasible Multi-Gene Expression Assay for Predicting Metastasis in Uveal Melanoma. Journal of Molecular Diagnostics. 12(4). 461–468. 243 indexed citations

Ehlers, Justis P., Lori A. Worley, Michael D. Onken, & J. William Harbour. (2008). Integrative Genomic Analysis of Aneuploidy in Uveal Melanoma. Clinical Cancer Research. 14(1). 115–122. 87 indexed citations

10.

Worley, Lori A., et al.. (2008). Micro-RNAs associated with metastasis in uveal melanoma identified by multiplexed microarray profiling. Melanoma Research. 18(3). 184–190. 126 indexed citations

11.

Onken, Michael D., et al.. (2008). Oncogenic Mutations in GNAQ Occur Early in Uveal Melanoma. Investigative Ophthalmology & Visual Science. 49(12). 5230–5230. 258 indexed citations

12.

Worley, Lori A., et al.. (2007). Transcriptomic versus Chromosomal Prognostic Markers and Clinical Outcome in Uveal Melanoma. Clinical Cancer Research. 13(5). 1466–1471. 124 indexed citations

13.

Onken, Michael D., et al.. (2007). Loss of Heterozygosity of Chromosome 3 Detected with Single Nucleotide Polymorphisms Is Superior to Monosomy 3 for Predicting Metastasis in Uveal Melanoma. Clinical Cancer Research. 13(10). 2923–2927. 95 indexed citations

14.

Onken, Michael D., et al.. (2006). Functional Gene Expression Analysis Uncovers Phenotypic Switch in Aggressive Uveal Melanomas. Cancer Research. 66(9). 4602–4609. 130 indexed citations

15.

Onken, Michael D., Lori A. Worley, Rosa M. Dávila, Devron H. Char, & J. William Harbour. (2006). Prognostic Testing in Uveal Melanoma by Transcriptomic Profiling of Fine Needle Biopsy Specimens. Journal of Molecular Diagnostics. 8(5). 567–573. 52 indexed citations

16.

Onken, Michael D., Amy Lin, Lori A. Worley, Robert Folberg, & J. William Harbour. (2005). Association Between Microarray Gene Expression Signature and Extravascular Matrix Patterns in Primary Uveal Melanomas. American Journal of Ophthalmology. 140(4). 748–749. 36 indexed citations

17.

Worley, Lori A., et al.. (2005). Loss of Rb-E2F Repression Results in Caspase-8-mediated Apoptosis through Inactivation of Focal Adhesion Kinase. Journal of Biological Chemistry. 280(11). 10484–10490. 17 indexed citations

18.

Sun, Yang, Binh N. Tran, Lori A. Worley, Rachel B. Delston, & J. William Harbour. (2005). Functional Analysis of the p53 Pathway in Response to Ionizing Radiation in Uveal Melanoma. Investigative Ophthalmology & Visual Science. 46(5). 1561–1561. 37 indexed citations

19.

Onken, Michael D., Lori A. Worley, Justis P. Ehlers, & J. William Harbour. (2004). Gene Expression Profiling in Uveal Melanoma Reveals Two Molecular Classes and Predicts Metastatic Death. Cancer Research. 64(20). 7205–7209. 514 indexed citations breakdown →

20.

Brantley, Milam A., Lori A. Worley, & J. William Harbour. (2002). Altered expression of rb and p53 in uveal melanomas following plaque radiotherapy. American Journal of Ophthalmology. 133(2). 242–248. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact